Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · July 03, 2023

Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss

Obstetrics and Gynecology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Obstetrics and Gynecology
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial
Obstet Gynecol 2023 Jun 01;141(6)1115-1123, A Henkel, SA Johnson, MF Reeves, et al

Further Reading